<DOC>
	<DOCNO>NCT02503085</DOCNO>
	<brief_summary>The purpose study determine rate extent absorption Ibuprofen suspension formulation .</brief_summary>
	<brief_title>Ibuprofen Suspension Bioequivalence Study</brief_title>
	<detailed_description />
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Subjects give write informed consent . Age : ≥ 18 year ≤ 50 year . Sex : Male female subject eligible entry . Female subject child bear potential negative pregnancy test screen visit willing use effective method contraception , child bear potential Male subject willing use effective method contraception , unless anatomically sterile Status : healthy subject determine past medical history , physical examination , vital sign , electrocardiogram , laboratory test screen . Healthy Subjects Body Mass Index ( BMI ) ≥18 ≤30 kg/m2 Pregnancy lactate female subject . A history significant disease body system . Any condition may currently interfere absorption , distribution , metabolism excretion drug . A history allergy intolerance relate treatment ibuprofen , aspirin NonSteroidal Antiinflammatory Disease , excipients formulation . A history active peptic duodenal ulcer gastrointestinal bleed upper gastrointestinal bleed , significant gastrointestinal disorder . A history frequent dyspepsia , e.g . heartburn indigestion . A history migraine . A history psychotic illness , attempt suicide parasuicide . Current smoker exsmokers smoke within 6 month . A history drug abuse ( include alcohol ) . High consumption stimulate drink ( caffeine intake per day 300 mg ) . Those positive drug abuse screen include alcohol occasion throughout study . Ingestion prescribe drug time 14 day dose study medication ( exclude hormonal contraceptive hormone replacement therapy ) , consumption enzyme inhibitor inducer previous month ( barbiturate , carbamazepine , erythromycin , phenytoin , etc. ) . Ingestion overthecounter preparation within 7 day dose study medication . Donation blood quantity previous 12 week enrolment study . Known human immune deficiency virus ( HIV ) positive status , positive viral serology screen . Topical use ibuprofen within 7 day dose study medication . Those previously randomise study . Employee study site . Partner first degree relative Investigator . Those participated clinical trial previous 12 week . Those unable opinion Investigator comply fully study requirement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>